Omeros (OMER) EV to Revenue (2009 - 2026)

Omeros (OMER) EV to Revenue (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to Revenue
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 44.65 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 3,489.42
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 41.13
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 8.66
9 Abivax 90.15 Bn 90.15 Bn - 17,434.90
10 Omeros 628.56 Mn 493.24 Mn 9.31 Mn 7.18

Historic Data

Download Data
DateValue
Jun 12, 2026 7.18
Jun 11, 2026 8.73
Jun 10, 2026 8.72
Jun 9, 2026 8.46
Jun 8, 2026 8.39
Jun 5, 2026 8.28
Jun 4, 2026 8.76
Jun 3, 2026 8.66
Jun 2, 2026 8.76
Jun 1, 2026 9.27
May 29, 2026 9.58
May 28, 2026 9.70
May 27, 2026 9.62
May 26, 2026 10.23
May 22, 2026 10.02
May 21, 2026 10.55
May 20, 2026 11.03
May 19, 2026 10.45
May 18, 2026 10.27
May 15, 2026 10.85